Ralf Pasternack

926 total citations
25 papers, 601 citations indexed

About

Ralf Pasternack is a scholar working on Pulmonary and Respiratory Medicine, Hematology and Gastroenterology. According to data from OpenAlex, Ralf Pasternack has authored 25 papers receiving a total of 601 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 6 papers in Hematology and 6 papers in Gastroenterology. Recurrent topics in Ralf Pasternack's work include Blood properties and coagulation (18 papers), Celiac Disease Research and Management (6 papers) and Microscopic Colitis (5 papers). Ralf Pasternack is often cited by papers focused on Blood properties and coagulation (18 papers), Celiac Disease Research and Management (6 papers) and Microscopic Colitis (5 papers). Ralf Pasternack collaborates with scholars based in Germany, Japan and United States. Ralf Pasternack's co-authors include Hans‐Lothar Fuchsbauer, Martin Hils, Sabine Wolf, Simone Dorsch, Christiane Pelzer, Andreas Heil, Jens Zotzel, Yoshiyuki Kumazawa, G. Klebe and A. Heine and has published in prestigious journals such as Angewandte Chemie International Edition, Gastroenterology and Analytical Biochemistry.

In The Last Decade

Ralf Pasternack

25 papers receiving 578 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ralf Pasternack Germany 13 333 162 148 116 89 25 601
Martin Hils Germany 12 159 0.5× 68 0.4× 42 0.3× 128 1.1× 27 0.3× 18 388
Vahid Arabkari Ireland 8 40 0.1× 317 2.0× 33 0.2× 28 0.2× 107 1.2× 14 495
Joshua Goyert United States 4 41 0.1× 205 1.3× 33 0.2× 8 0.1× 43 0.5× 8 315
Chunli Zhou China 13 40 0.1× 291 1.8× 14 0.1× 52 0.4× 54 0.6× 36 614
Mingli Zhao China 14 124 0.4× 228 1.4× 18 0.1× 62 0.5× 15 0.2× 56 551
Alexandra Blatt Israel 7 73 0.2× 244 1.5× 32 0.2× 12 0.1× 16 0.2× 9 464
Jain Zhou United States 9 57 0.2× 197 1.2× 38 0.3× 14 0.1× 28 0.3× 14 479
Sophie Van Welden Belgium 9 26 0.1× 236 1.5× 11 0.1× 42 0.4× 24 0.3× 15 530
Slavica S. Matacic United States 9 240 0.7× 140 0.9× 49 0.3× 3 0.0× 31 0.3× 10 406

Countries citing papers authored by Ralf Pasternack

Since Specialization
Citations

This map shows the geographic impact of Ralf Pasternack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ralf Pasternack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ralf Pasternack more than expected).

Fields of papers citing papers by Ralf Pasternack

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ralf Pasternack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ralf Pasternack. The network helps show where Ralf Pasternack may publish in the future.

Co-authorship network of co-authors of Ralf Pasternack

This figure shows the co-authorship network connecting the top 25 collaborators of Ralf Pasternack. A scholar is included among the top collaborators of Ralf Pasternack based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ralf Pasternack. Ralf Pasternack is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Isola, Jorma, Markku Mäki, Martin Hils, et al.. (2023). The Oral Transglutaminase 2 Inhibitor ZED1227 Accumulates in the Villous Enterocytes in Celiac Disease Patients during Gluten Challenge and Drug Treatment. International Journal of Molecular Sciences. 24(13). 10815–10815. 14 indexed citations
2.
Pasternack, Ralf, et al.. (2021). Clinical Validation of an Automated Fluorogenic Factor XIII Activity Assay Based on Isopeptidase Activity. International Journal of Molecular Sciences. 22(3). 1002–1002. 7 indexed citations
3.
Heine, A., et al.. (2020). Structure‐Based Design of FXIIIa‐Blockers: Addressing a Transient Hydrophobic Pocket in the Active Site of FXIIIa. ChemMedChem. 15(10). 900–905. 4 indexed citations
4.
Pasternack, Ralf, et al.. (2020). Feasibility of an automated coagulation factor XIIIa test using its isopeptidase activity. Analytical Biochemistry. 600. 113757–113757. 2 indexed citations
5.
Pasternack, Ralf, et al.. (2020). Nucleotide binding kinetics and conformational change analysis of tissue transglutaminase with switchSENSE. Analytical Biochemistry. 605. 113719–113719. 11 indexed citations
6.
Pasternack, Ralf, Christiane Pelzer, Michael Sommer, et al.. (2019). Novel inhibitor ZED3197 as potential drug candidate in anticoagulation targeting coagulation FXIIIa (F13a). Journal of Thrombosis and Haemostasis. 18(1). 191–200. 28 indexed citations
7.
Wilhelmus, Micha M.M., Wissam Beaino, Esther Kooijman, et al.. (2018). In vivo evaluation of two tissue transglutaminase PET tracers in an orthotopic tumour xenograft model. EJNMMI Research. 8(1). 39–39. 6 indexed citations
8.
Wilhelmus, Micha M.M., Esther Kooijman, Cornelis A.M. Jongenelen, et al.. (2016). Development of fluorine-18 labeled peptidic PET tracers for imaging active tissue transglutaminase. Nuclear Medicine and Biology. 44. 90–104. 8 indexed citations
10.
Pasternack, Ralf, et al.. (2014). Microbial Transglutaminase Treatment in Pasta-Production Does Not Affect the Immunoreactivity of Gliadin with Celiac Disease Patients’ Sera. Journal of Agricultural and Food Chemistry. 62(30). 7604–7611. 19 indexed citations
11.
Heil, Andreas, et al.. (2013). Differences in the inhibition of coagulation factor XIII-A from animal species revealed by Michael Acceptor– and thioimidazol based blockers. Thrombosis Research. 131(5). e214–e222. 10 indexed citations
12.
13.
Hils, Martin, et al.. (2013). Structure of Active Coagulation Factor XIII Triggered by Calcium Binding: Basis for the Design of Next‐Generation Anticoagulants. Angewandte Chemie International Edition. 52(45). 11930–11934. 62 indexed citations
14.
Elli, Luca, Leda Roncoroni, Martin Hils, et al.. (2012). Immunological effects of transglutaminase-treated gluten in coeliac disease. Human Immunology. 73(10). 992–997. 34 indexed citations
15.
McConoughey, Stephen J., Zoya Niatsetskaya, Ralf Pasternack, et al.. (2009). A nonradioactive dot blot assay for transglutaminase activity. Analytical Biochemistry. 390(1). 91–93. 7 indexed citations
16.
Hunfeld, A., et al.. (2007). A highly sensitive fluorometric assay for determination of human coagulation factor XIII in plasma. Analytical Biochemistry. 367(2). 152–158. 46 indexed citations
17.
Zotzel, Jens, et al.. (2003). Activated transglutaminase from Streptomyces mobaraensis is processed by a tripeptidyl aminopeptidase in the final step. European Journal of Biochemistry. 270(20). 4149–4155. 63 indexed citations
19.
Pasternack, Ralf, et al.. (1998). Bacterial pro‐transglutaminase from Streptoverticillium mobaraense. European Journal of Biochemistry. 257(3). 570–576. 133 indexed citations
20.
Pasternack, Ralf, et al.. (1997). A Fluorescent Substrate of Transglutaminase for Detection and Characterization of Glutamine Acceptor Compounds. Analytical Biochemistry. 249(1). 54–60. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026